Mid CDMO

Anthem Biosciences Ltd.

ANTHEM

Market Cap
₹43,724 Cr.
P/E
73.88

Anthem Biosciences Ltd.

  • Anthem Biosciences
  • Syngene Internatl.
  • Sai Life Sciences

FAQs on Anthem Biosciences Ltd. Shareprice

There is not enough historical data for the companies share price.

Anthem Biosciences is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Anthem Biosciences is 73.88, while 3 year average PE is 86.12.
Also latest EV/EBITDA of Anthem Biosciences is 52.17 while 3yr average is 51.71.

View FAQ's On Business

Growth Table

  • Anthem Biosciences Ltd.
  • Syngene Internatl.
  • Sai Life Sciences

Balance Sheet

  • Anthem Biosciences Ltd.
  • Syngene Internatl.
  • Sai Life Sciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Anthem Biosciences Ltd.
  • Syngene Internatl.
  • Sai Life Sciences

Cash Flow

  • Anthem Biosciences Ltd.
  • Syngene Internatl.
  • Sai Life Sciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Anthem Biosciences Ltd.
  • Syngene Internatl.
  • Sai Life Sciences

Quarterly Results

  • Anthem Biosciences Ltd.
  • Syngene Internatl.
  • Sai Life Sciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Anthem Biosciences Ltd. Financials

Balance sheet of Anthem Biosciences is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Anthem Biosciences is decreasing.
Latest net debt of Anthem Biosciences is -₹498.69 Crs as of Mar-26.
This is less than Mar-25 when it was -₹235.61 Crs.

Yes, profit is increasing.
The profit of Anthem Biosciences is ₹592 Crs for Mar 2026, ₹451 Crs for Mar 2025 and ₹367 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Anthem Biosciences latest dividend payout ratio is 18.98% and 3yr average dividend payout ratio is 18.98%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech